Expert Interview
A second look: Discussing IL-33 agents in development for COPD with a focus on Itepekimab
Ticker(s): REGN, SNYInstitution: Cherokee Lung & Sleep Specialists
- Community Pulmonologist who specializes in COPD, asthma, pulmonary nodules and cancers, obstructive and central sleep apneas, complex sleep-disordered breathing, narcolepsy, restless leg syndrome, circadian rhythm disorders and insomnia.
- 250 COPD patients annually approximately
- Very familiar with investigational agents in development for COPD
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
